Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 10 save search
Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
Published: 2021-08-10 (Crawled : 13:00) - biospace.com/
FULC | $7.16 -3.37% -3.49% 400K
|
Health Technology
|
| O: 58.58%
H: 67.22%
C: 42.09%
financial results results
Fulcrum Therapeutics Announces Positive Interim Results from Phase 1 Healthy Adult Volunteer Trial of FTX-6058 for Sickle Cell Disease
Published: 2021-08-10 (Crawled : 13:00) - biospace.com/
FULC | $7.16 -3.37% -3.49% 400K
|
Health Technology
|
| O: 58.58%
H: 67.22%
C: 42.09%
disease phase 1 positive results trial phase 2 phase 3
Lightning eMotors and Forest River Inc. Reach Multiyear Agreement for up to $850M in Zero-Emission Bus Technology Plus Charging Products and Services
Published: 2021-08-10 (Crawled : 12:00) - lightningemotors.com
ZEV | $1.63 0.0% 79K
|
Manufacturing
|
| O: 54.13%
H: 22.47%
C: 17.41%
technology charging
Pixelworks Reports Second Quarter 2021 Financial Results and Announces Realignment Plan and Strategic Equity Investments Into Pixelworks Shanghai
Published: 2021-08-10 (Crawled : 20:00) - prnewswire.com
PXLW | $1.685 -6.13% -6.53% 280K
|
Electronic Technology
|
| O: 0.28%
H: 15.91%
C: 14.16%
financial results results
Smith-Midland Reports Second Quarter 2021 Financial Results
Published: 2021-08-10 (Crawled : 12:15) - smithmidland.com
SMID 4 | $38.655 -3.15% -3.25% 11K
|
Non-Energy Minerals
|
| O: 0.78%
H: 15.29%
C: 12.39%
financial results results
Xenon Pharmaceuticals to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference
Published: 2021-08-10 (Crawled : 22:00) - globenewswire.com
XENE | $41.61 0.29% 0.29% 390K
|
Health Technology
|
| O: 0.83%
H: 12.75%
C: 10.27%
conference
Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results
Published: 2021-08-10 (Crawled : 20:00) - prnewswire.com
RLMD | $4.67 2.41% 2.36% 85K
|
Health Technology
|
| O: -4.17%
H: 8.12%
C: 7.94%
financial results results
Rezolute Announces Initiation of Multiple-Ascending Dose Study of RZ402, Rezolute’s Oral PKI for Treatment of DME
Published: 2021-08-10 (Crawled : 18:00) - biospace.com/
RZLT 4 | $3.23 -5.0% -5.26% 430K
|
Technology Services
|
| O: -1.03%
H: 11.27%
C: 7.48%
treatment
Stagwell Inc. (STGW) Announces Offering of Senior Notes to Refinance Existing Debt
Published: 2021-08-10 (Crawled : 12:00) - prnewswire.com
STGW F | $5.3 -2.03% -2.08% 600K
|
|
| O: -1.32%
H: 8.42%
C: 6.67%
offering
Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2021 Financial Results
Published: 2021-08-10 (Crawled : 11:00) - globenewswire.com
CGEM | $17.84 3.0% 2.91% 1.3M
|
|
| O: 0.11%
H: 7.86%
C: 6.58%
financial results results
Mesa Air Group Reports July 2021 Operating Performance
Published: 2021-08-10 (Crawled : 22:00) - globenewswire.com
MESA | $0.8 -1.22% 88K
|
Transportation
|
| O: -0.12%
H: 6.36%
C: 6.23%
EyePoint Pharmaceuticals to Present at the H.C. Wainwright Ophthalmology Virtual Conference
Published: 2021-08-10 (Crawled : 18:00) - biospace.com/
EYPT | $20.94 -4.12% -4.3% 510K
|
Health Technology
|
| O: 0.76%
H: 6.64%
C: 6.21%
eye conference
HF Foods Reports Strong Second Quarter 2021 Financial Results. Net Revenue up 85.1% to $193.5 Million With Net Income Attributable to the Company of $3.6 Million and a 249.2% Increase in Adjusted EBITDA to $11.9 Million
Published: 2021-08-10 (Crawled : 13:00) - hffoodsgroup.com
HFFG | $3.15 -1.25% -1.27% 26K
|
Distribution Services
|
| O: 0.76%
H: 7.2%
C: 6.06%
food financial results
Verrica Pharmaceuticals Reports Second Quarter 2021 Financial Results
Published: 2021-08-10 (Crawled : 12:00) - globenewswire.com
VRCA | $7.09 1.29% 1.27% 110K
|
Health Technology
|
| O: -1.2%
H: 6.64%
C: 5.99%
financial results results
Senior Scientist/Principal Scientist, Protein Purification Process Development
Published: 2021-08-10 (Crawled : 19:00) - cuebiopharma.com
CUE | $1.63 9.03% 8.28% 320K
|
Health Technology
|
| O: 1.03%
H: 6.41%
C: 5.95%
ev
Senior Scientist/Principal Scientist, Upstream Cell Culture Process Development
Published: 2021-08-10 (Crawled : 19:00) - cuebiopharma.com
CUE | $1.63 9.03% 8.28% 320K
|
Health Technology
|
| O: 1.03%
H: 6.41%
C: 5.95%
Human Resources Generalist
Published: 2021-08-10 (Crawled : 19:00) - cuebiopharma.com
CUE | $1.63 9.03% 8.28% 320K
|
Health Technology
|
| O: 1.03%
H: 6.41%
C: 5.95%
SandRidge Energy, Inc. Announces Financial And Operating Results For The Three And Six Month Periods Ended June 30, 2021; Announces Share Repurchase Program
Published: 2021-08-10 (Crawled : 22:00) - prnewswire.com
SD | $14.29 -1.45% 0.0% 200K
|
Energy Minerals
|
| O: 5.59%
H: 6.65%
C: 5.94%
energy results
Olema Oncology Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-08-10 (Crawled : 21:00) - globenewswire.com
OLMA | $10.72 -0.92% -0.93% 510K
|
Health Technology
|
| O: -0.93%
H: 7.49%
C: 5.92%
financial results results
ORIC Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Update
Published: 2021-08-10 (Crawled : 21:00) - globenewswire.com
ORIC | $9.79 3.6% 3.47% 510K
|
Health Technology
|
| O: 1.49%
H: 6.87%
C: 5.41%
financial results results
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.